Abstract
Pulmonary alveolar proteinosis is a rare lung disease in which lipoproteinaceous material accumulates within the alveoli, interfering with gas exchange. The disease is classified into congenital, secondary, and acquired. The congenital form includes inborn errors of surfactant metabolism, lysinuric protein intolerance and mutations in the components of granulocyte-macrophage colony-stimulating factor receptor. The main symptoms are non-specific. The radiologic appearance of pulmonary alveolar proteinosis is bilateral, symmetric and perihilar airspace consolidation. Bronchoalveolar lavage is crucial for diagnosis of the disease. There is only one ten-year-old patient with diagnosed congenital form in Croatia. What makes him different from other children in the world is that since the ninth month of his life he has been mechanically ventilated. Diagnosis of postnatal alveolar proteinosis should be considered in every infant with respiratory distress with diffuse alveolar and interstitial infiltrate.
Abbreviations
- CAP:
-
Congenital alveolar proteinosis
- PAP:
-
Pulmonary alveolar proteinosis
- RDS:
-
Respiratory distress syndrome
- ICU:
-
Intensive care unit
- EDTA:
-
Ethylene-diamine tetraacetic acid (edetic acid)
- SIMV:
-
Synchronized intermittent mandatory ventilation
- CPAP:
-
Continuous positive airway pressure
- PEEP:
-
Positive end-expiratory pressure
- GM-CSF:
-
Granulocyte-macrophage colony-stimulating factor
- PAS:
-
Periodic acid–Schiff
References
Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med. 2002;166:215–35.
Hildebrandt J, Yalcin E, Bresser HG, et al. Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis. Orphanet J Rare Dis. 2014;9:171.
Doan ML, Guillerman RP, Dishop MK, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax. 2008;63:366–73.
Holbert JM. CT features of pulmonary alveolar proteinosis. AJR. 2001;176:1287–94.
de Vega MG, Sánchez-Palencia A, Ramírez A, Cervera S, Aneiros J. GM-CSF therapy in pulmonary alveolar proteinosis. Thorax. 2002;57:837–8.
de Blic J. Pulmonary alveolar proteinosis in children. Pediatr Respir Rev. 2004;5:316–22.
Hammami S, Harrathi K, Lajmi K, Hadded S, Meriem CB, Guédiche MN. Congenital pulmonary alveolar proteinosis. Case Rep Pediatr. 2013;2013. doi:10.1155/2013/764216.
Author information
Authors and Affiliations
Contributions
SAK: Conception and design of the case report and drafted the manuscript. LP: Critical revision of the manuscript, final approval of the version to be published and agreement to be accountable for all aspects of the work. Both the authors have participated sufficiently in the work to take public responsibility for the contents. LP will act as guarantor for the paper.
Corresponding author
Ethics declarations
Conflict of Interest
None.
Source of Funding
None.
Rights and permissions
About this article
Cite this article
Alavuk Kundović, S., Popović, L. Congenital Pulmonary Alveolar Proteinosis: From Birth to Ten-years of Age. Indian J Pediatr 84, 721–723 (2017). https://doi.org/10.1007/s12098-017-2365-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-017-2365-6